Currently, less than 5% of government funding for medical research goes into surgery
One of only nine Royal College of Surgeons specialist trial centres across the whole of the UK, SITU is a collaboration between the Nuffield Department of Surgical Sciences (NDS) and the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS). We have an extensive portfolio of surgical trials and welcome expressions of interest from potential new researchers.
More information about NDS SITU and our work within surgical research can be found by following the links below.
About Us
Our Surgical Trials
Work With Us
NDS SITU Mission Statement |
|
NDS SITU Core Principle |
We design, develop, and deliver high quality, innovative and impactful surgical trials using novel methodologies and technologies to shape the future of trial-based research and pave the way for evolution in clinical practice. | We have established a nurturing environment that promotes continuous learning and development for all of our staff and collaborators, and together we have an unfaltering dedication to implementing meaningful improvements in patient care and experience. |
Latest News
The NIHR recently interviewed Rachel Rolph, Chief Investigator of the Restore-B trial into whether mesh should be used in breast reconstruction after surgery for breast cancer. Read the Q&A.
Latest publications
-
Predicting future fallers in Parkinson's disease using kinematic data over a period of 5 years.
Journal article
Sotirakis C. et al, (2024), NPJ Digit Med, 7
-
A systematic methodology review of fluorescence-guided cancer surgery to inform the development of a core master protocol and outcome set
Journal article
Vallance AE. et al, (2024), BMC Cancer, 24
-
Cortico-thalamic tremor circuits and their associations with deep brain stimulation effects in essential tremor.
Journal article
He S. et al, (2024), Brain
-
Muscarinic receptors mediate motivation via preparatory neural activity in humans
Journal article
Grogan JP. et al, (2024), eLife, 13